PRODUCTS
SERVICES
COMPANY
CONTACT
FAQ
Search
Dictionary
Mobile
Login
Login/Nickname:
Password:
Remember login
Login
Send password reminder...
Frances A Shepherd Selected Research
Adjuvant Chemotherapy
12/2007
Cancer Care Ontario and American Society of Clinical Oncology adjuvant chemotherapy and adjuvant radiation therapy for stages I-IIIA resectable non small-cell lung cancer guideline.
11/2007
Prognostic and predictive importance of p53 and RAS for adjuvant chemotherapy in non small-cell lung cancer.
01/2007
Referral patterns for adjuvant chemotherapy in patients with completely resected non-small cell lung cancer.
05/2006
Adjuvant chemotherapy for completely resected non-small cell lung cancer: a systematic review.
02/2006
Adjuvant chemotherapy for resected non-small cell lung cancer.
10/2005
Adjuvant Chemotherapy for Early-Stage Non-small Cell Lung Cancer.
03/2005
Compliance with post-operative adjuvant chemotherapy in non-small cell lung cancer. An analysis of National Cancer Institute of Canada and intergroup trial JBR.10 and a review of the literature.
Articles by Research Topic
Disease
40
Small Cell Carcinoma
07/2008 - 03/2002
10
Lung Neoplasms (Lung Cancer)
06/2008 - 08/2003
2
Neoplasms (Cancer)
12/2007 - 11/2002
1
Lung Diseases (Lung Disease)
06/2007
1
Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2005
Drug/Important Bio-Agent (IBA)
8
erlotinib (CP 358,774)
FDA Link
05/2008 - 07/2005
6
Cisplatin (Platino)
FDA Link
Generic
07/2008 - 08/2003
5
Epidermal Growth Factor Receptor (EGF Receptor)
IBA
03/2008 - 05/2006
4
docetaxel (Taxotere)
FDA Link
06/2006 - 03/2002
3
Epidermal Growth Factor (EGF)
IBA
05/2008 - 07/2003
3
Carboplatin (JM8)
FDA Link
Generic
04/2008 - 04/2005
3
vinorelbine (Navelbine)
FDA Link
Generic
06/2007 - 08/2003
3
Angiogenesis Inhibitors
IBA
10/2004 - 08/2003
2
Paclitaxel (Taxol)
FDA Link
Generic
04/2008 - 04/2005
2
gemcitabine
FDA Link
12/2007 - 08/2003
2
Protein-Tyrosine Kinases (Tyrosine Kinase)
IBA
05/2006 - 01/2006
2
Platinum
IBA
05/2005 - 02/2004
2
pemetrexed (MTA)
FDA Link
05/2004 - 12/2002
1
Phosphotransferases (Kinase)
IBA
04/2008
1
4- ((4- Fluoro- 2- methyl- 1H- indol- 5- yl)oxy)- 6- methoxy- 7- (3- (pyrrolidin- 1- yl)propoxy)quinazoline (AZD2171)
IBA
04/2008
1
Tyrosine (L-Tyrosine)
FDA Link
04/2008
1
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
04/2008
1
cetuximab (Erbitux)
FDA Link
12/2007
1
Messenger RNA (mRNA)
IBA
06/2007
1
Tubulin
IBA
02/2007
1
Topotecan (Hycamtin)
FDA Link
06/2006
1
gefitinib (Iressa)
FDA Link
05/2006
1
pipoxolan (BR 18)
IBA
04/2005
1
N-((2S)-2-mercapto-1-oxo-4-(3,4,4- trimethyl- 2,5- dioxo- 1- imidazolidinyl)butyl)- L- leucyl- N,3- dimethyl-L-Valinamide
IBA
04/2005
1
prinomastat (Ag3340)
IBA
02/2005
1
Vindesine (Vindesin)
IBA
01/2005
1
Filgrastim (Neupogen)
FDA Link
01/2005
1
Mitomycin (Mitomycin-C)
FDA Link
Generic
01/2005
1
Vincristine (Oncovin)
FDA Link
Generic
09/2003
1
Cyclophosphamide (Cytoxan)
FDA Link
Generic
09/2003
1
Doxorubicin (Adriamycin)
FDA Link
Generic
09/2003
1
pegylated liposomal doxorubicin
IBA
09/2003
1
Proto-Oncogene Proteins c-akt (Protein Kinase B)
IBA
06/2003
1
Protein Kinases (Protein Kinase)
IBA
06/2003
1
marimastat
IBA
11/2002
Therapy/Procedure
13
Drug Therapy (Chemotherapy)
07/2008 - 06/2002
7
Adjuvant Chemotherapy
12/2007 - 03/2005
1
Immunotherapy
06/2008
1
Biological Therapy
08/2003